Back to Search

LYDIA NORTON, MD

MD

Pediatrics Physician

NPI: 1366419442Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

M3672(TX)

Research & Publications (20)

Adjuvant chemotherapy in older women with early-stage breast cancer.
PMID 19439741·N Engl J Med·2009
4-observational
The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats.
PMID 19403715·J Nutr·2009
7-preclinical
Latent bone metastasis in breast cancer tied to Src-dependent survival signals.
PMID 19573813·Cancer Cell·2009
8-other
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
PMID 18306034·Breast Cancer Res Treat·2009
3-trial
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.
PMID 18751888·Breast Cancer Res Treat·2009
3-trial
Continuous EEG monitoring in severe Guillain-Barré syndrome patients.
PMID 19151618·J Clin Neurophysiol·2009
5-case
Encapsulation and quantification of multiple dye guests in unmodified poly(amidoamine) dendrimers as a function of generation.
PMID 19362221·Talanta·2009
8-other
Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia.
PMID 19445675·BMC Cancer·2009
8-other
Seizure detection with a commercially available bedside EEG monitor and the subhairline montage.
PMID 19585276·Neurocrit Care·2009
3-trial
Successful treatment with daclizumab of refractory anaplastic lymphoma.
PMID 19598219·Pediatr Blood Cancer·2009
5-case
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
PMID 18398145·J Clin Oncol·2008
3-trial
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
PMID 18332475·J Clin Oncol·2008
3-trial
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
PMID 18375893·J Clin Oncol·2008
3-trial
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.
PMID 18390970·J Clin Oncol·2008
2-rct
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.
PMID 18332473·J Clin Oncol·2008
8-other
Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
PMID 18363180·Pediatr Hematol Oncol·2008
5-case
Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates.
PMID 18413559·Arch Intern Med·2008
8-other
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.
PMID 18323546·J Clin Oncol·2008
3-trial
Changing indications for surgery in patients with stage IV breast cancer: a current perspective.
PMID 18306353·Cancer·2008
4-observational
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.
PMID 18326623·Proc Natl Acad Sci U S A·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2499 S CAPITAL OF TEXAS HWY STE 100
AUSTIN, TX 78746

Location

Practice Location

2499 S CAPITAL OF TEXAS HWY STE 100, AUSTIN, TX
(512) 328-7666

Quick Facts

NPI
1366419442
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile